title: Eptifibatide-Induced Thrombocytopenia--When Inhibitor Turns Killer.
abstract: Eptifibatide is a commonly and widely used drug for management of acute coronary syndrome and during percutaneous coronary intervention. It is usually well tolerated with no major adverse effects. We report a rare case of life-threatening thrombocytopenia secondary to eptifibatide along with a literature review of available evidence.
authors.affiliation: Departments of 1Internal Medicine and 2Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR.
authors.forename: Naga Venkata
authors.initials: NV
authors.lastname: Pothineni
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Watts
authors.forename: Zufeng
authors.initials: Z
authors.lastname: Ding
authors.forename: Yao
authors.initials: Y
authors.lastname: Dai
authors.forename: Abhishek J
authors.initials: AJ
authors.lastname: Deshmukh
mesh_terms: D000368:Aged; D000077542:Eptifibatide; D006801:Humans; D008297:Male; D010455:Peptides / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077542:Eptifibatide